Skip to main content
MarketStoryBook

Fresenius SE & Co. KGaA in 1 story

The narratives FRE.DE currently appears in, with its side and exposure in each.

Bull side

1 story
  • America Imports the World's Drug Prices

    FRE.DE in “America Imports the World's Drug Prices”

    StableExposure: not rated yet

    US reference pricing puts global blockbuster economics—and not just American list prices—under pressure.

    Fresenius benefits through Fresenius Kabi's generic injectables and biosimilars, which offer health systems practical tools for reducing branded-drug spending.

Bear side

0 stories

No bear-side stories for FRE.DE yet.